Bristol Myers Squibb
BMY·NEW YORK STOCK EXCHANGE, INC.
Compare PeersSnapshot
Valuation
Market Cap
P/E (TTM)
P/Sales
EV/EBITDA
P/Book
Cash Flow
Operating CF$13.31B
Free Cash Flow$11.91B
FCF Yield
Margins & Growth
Gross Margin70.46%
Oper. Margin34.06%
Net Margin15.01%
Balance Sheet
Cash$10.49B
Total Assets$86.48B
Total Debt$46.45B
Dividends
Div Yield
DPS (TTM)$2.50
Net Debt$35.96B
Company Profile
CEO
Dr. Christopher S. Boerner Ph.D.
Website
Sector
Health Care
Industry
Pharmaceuticals
Full Time Employees
-
Country
US
Exchange
NEW YORK STOCK EXCHANGE, INC.
A Bristol Myers Squibb é uma empresa biofarmacêutica focada em tratamentos de alta complexidade. A empresa gera receitas vendendo medicamentos inovadores nas áreas da oncologia, hematologia e doenças cardiovasculares.
